Sharon McGrath-Morrow is a professor in the Department of Pediatrics at the Johns Hopkins School of Medicine with a joint appointment in the Department of Environmental Health Sciences at the Bloomberg School of Public Health. Dr. McGrath-Morrow is also the Johns Hopkins Pediatric Pulmonary Fellowship Director, a fellow of the American Academy of Pediatrics and a member of the American Academy of Pediatric Tobacco Consortium. She is a pediatric pulmonologist and clinician scientist who runs a translational laboratory modeling neonatal lung injury. Her research interests include understanding the neonatal immune response to acute lung injury, respiratory outcomes in preterm infants with chronic lung disease and the impact of secondhand and thirdhand smoke on postnatal lung growth and adult lung function. Dr. McGrath-Morrow received her M.D. from the University of Virginia.
David Mendez is an associate professor in the Department of Health Management and Policy at the University of Michigan, School of Public Health. His research focuses on the application of mathematical/computational models for public health policy, particularly in the field of tobacco control. He has conducted research on the impact of tobacco control policies on smoking prevalence and health outcomes. He has also been involved in research to evaluate policies regarding residential radon and the uptake of the HPV vaccine. He is currently engaged in a study to evaluate the impact of peer pressure on smoking uptake among teenagers using systems dynamics and agent-based models. He served on a prior committee of the National Academies assessing agent-based modeling in tobacco control. Dr. Mendez received his M.S. in applied statistics, M.S. in operations research/systems science and Ph.D. in management science from Michigan State University.
Richard Miech is a research professor at the Survey Research Center, Institute for Social Research, University of Michigan. Previously Dr. Miech had been a professor and department chair in the Department of Health and Behavioral Sciences at the University of Colorado Denver. His work focuses on trends in substance use, with an emphasis on disentangling how these trends vary by age, historical period, and birth cohort membership. His research interests also include the causes and consequences of substance use over the life course. Dr. Miech received his M.A. and Ph.D. in sociology from the University of North Carolina at Chapel Hill and a M.P.H. from Johns Hopkins University.
Ana Navas-Acien is a professor of Environmental Health Sciences at Columbia University Mailman School of Public Health. Dr. Navas-Acien’s research investigates the long-term health effects of widespread environmental exposures (arsenic and other metals, tobacco smoke, air pollution), their interactions with genetic and epigenetic variants, and effective interventions for reducing involuntary environmental exposures. For more than 10 years, she has been working on environment-related research in population-based cohort studies such as the Strong Heart Study, a study of cardiovascular disease and its risk factors in American Indian communities, and the Multi-Ethnic Study of Atherosclerosis (MESA), a study of cardiovascular, metabolic and lung disease in urban settings across the US. She has served on National Academies committees addressing inorganic arsenic and the scientific capabilities of the U.S. Environmental Protection Agency. Dr. Navas-Acien received her M.D. from the University of Granada, M.P.H. from the National School of Health, Madrid, Spain, and Ph.D. from Johns Hopkins University.
Kent E. Pinkerton
Kent Pinkerton is a professor in the Department of Pediatrics in the School of Medicine and the Department of Anatomy, Physiology, and Cell Biology in the School of Veterinary Medicine at the University of California, Davis. Dr. Pinkerton also serves as director of the University's Center for Health and the Environment. Dr. Pinkerton’s research interests focus on the health effects of environmental air pollutants on lung structure and function, the interaction of gases and airborne particles within specific sites and cell populations of the lungs in acute and chronic lung injury, and the effects of environmental tobacco smoke on lung growth and development. Prior to 2008, he received research support from Phillip Morris and has collaborated with other researchers who received research support from Phillip Morris. He previously served on committees of the National Academies related to estimating mortality risk reduction from decreasing tropospheric ozone exposure, formaldehyde risk assessment, and particulate matter surveillance. Dr. Pinkerton received his Ph.D. in pathology from Duke University.
Nancy A. Rigotti
Nancy Rigotti is a Professor of Medicine at Harvard Medical School and Associate Chief of the Division of General Internal Medicine at Massachusetts General Hospital. Dr. Rigotti has pioneered research on interventions to reduce smoking prevalence and the burden of tobacco-related morbidity and mortality. A general internist, her clinical research focuses on developing and disseminating interventions for smoking cessation within primary care practices and inpatient settings. She founded and directs the MGH Tobacco Research and Treatment Center. She is a Past President of the Society of General Internal Medicine and a Past President of the Society for Research in Nicotine and Tobacco. She was a Scientific Editor of the 1989 Surgeon General’s Report on Tobacco, a comprehensive review that provided scientific support for policymaking and she was a Deputy Editor of Nicotine & Tobacco Research. Dr. Rigotti received her M.D. from Harvard Medical School.
David A. Savitz
David A. Savitz is Vice President for Research at Brown University and Professor of Epidemiology in the Brown University School of Public Health, with a joint appointment in Obstetrics and Gynecology in the Alpert Medical School. His epidemiological research has addressed a wide range of many important public health issues including environmental hazards in the workplace and community, reproductive health outcomes, and environmental influences on cancer. He has done extensive work on health effects of nonionizing radiation, pesticides, drinking water treatment by-products, and perfluorinated compounds. He was the president of the Society for Epidemiologic Research and the Society for Pediatric and Perinatal Epidemiologic Research and North American Regional Councilor for the International Epidemiological Association. He was compensated by Best Practice Management Inc. through an unrestricted grant from Star Scientific to chair a panel discussion and author a 2006 summary paper on the public health implications of smokeless tobacco use as a harm reduction strategy. Dr. Savitz received his Master’s degree in Preventive Medicine from Ohio State University and Ph.D. in Epidemiology from the University of Pittsburgh Graduate School of Public Health. He is an elected member of the National Academy of Medicine.
Gideon St.Helen is an assistant professor of Medicine, Division of Clinical Pharmacology, Dept. of Medicine, at the University of California, San Francisco. The focus of his research program is the utility and evaluation of biological markers of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors. Dr. St.Helen received his Ph.D. in toxicology from the University of Georgia.